Loading stock data…
OSUR
$2.95-0.09 (-2.96%)
Market ClosedLast close May 1
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
OraSure Technologies, Inc. in the Healthcare sector is trading at $2.95. The stock is currently 23% below its 52-week high of $3.82, remaining 2.4% above its 200-day moving average. Technical signals show neutral RSI of 41 and bearish MACD signal, explaining why OSUR maintains its current momentum and trend strength. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 41) — price action in range
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$2.95
Potential Upside
5%
Whystock Fair Value$3.10
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally. It offers OraQuick Rapi...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$215.33M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.85
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-14.97%
Volume
Today's trading volume
304,241
Recent News
Why OraSure Technologies (OSUR) Is Back in the Spotlight as Sale Pressure Builds
OraSure Technologies, Inc. (NASDAQ:OSUR) is one of the 10 potential takeover targets with strong price momentum. On March 17, 2026, Reuters reported that activist investor Altai Capital Management pushed the company to explore a sale, arguing that OraSure could fetch roughly double its current share price. Altai also pressed for board seats after nominating directors, […]
OraSure Technologies, Inc. Q4 2025 Earnings Call Summary
Moby summary of OraSure Technologies, Inc.'s Q4 2025 earnings call
OraSure Technologies Q4 Earnings Call Highlights
OraSure Technologies (NASDAQ:OSUR) reported fourth-quarter 2025 revenue of $26.8 million, with management pointing to early signs of stabilization across key end markets after what it described as a transition year marked by a challenging funding environment. On the company’s earnings call, executiv
OraSure Technologies Inc (OSUR) Q4 2025 Earnings Call Highlights: Revenue Exceeds Expectations ...
Despite operating losses, OraSure Technologies Inc (OSUR) showcases strong revenue performance and strategic product expansions for 2026.
OraSure: Q4 Earnings Snapshot
OSUR) on Wednesday reported a loss of $19.3 million in its fourth quarter. On a per-share basis, the Bethlehem, Pennsylvania-based company said it had a loss of 27 cents. Losses, adjusted for non-recurring costs and stock option expense, were 19 cents per share.